WHO unites vaccine manufactures to fight flu epidemic

19 May 2009 @ 09:57 pm EDT

The World Health Organization’s Director General Dr. Margaret Chan met Tuesday with over 30 vaccine manufacturers from developing and developed countries at Geneva to fight flu epidemic.



WHO Director-General Margaret Chan (L) gestures next to United Nations Secretary-General Ban Ki-moon during a Vaccine Influenza A (H1N1) meeting with pharmaceuticals companies at the World Health Organization`s (WHO) headquarters in Geneva May 19, 2009.
1 of 1

"We have a very serious commitment from companies in the North and in the South to work with WHO," Dr. Chan said at a press conference.

She said WHO would work to find innovative funding mechanisms to ensure that developing countries were not denied access to vaccines because of lack of means.

"In the name of solidarity, I have reached out to drug and vaccine manufacturers, we will look at different mechanisms to make sure poor communities and countries are not left out," Dr Chan said.

The Director General said she would meet with vaccine manufactures individually to work out strategies to ensure pandemic vaccine availability.

In response to a question on pandemic alert phase change, Dr Chan explained that the definition of WHO's influenza preparedness phases was developed against the backdrop of H5N1 avian flu.

"Influenza A(H1N1) has a very different clinical picture, which is so far mostly mild and self-limiting, unlike H5N1, which had a 50% to 60% mortality rate," she said that at the on-going World Health Assembly, member States had asked that WHO reflect criteria other than geographical spread before moving to Phase 6.

The flu pandemic alert level is currently still at Phase 5.

This article is copyrighted by International Business Times.

E-Newsletters

We value your privacy. Your email address will not be shared.